Federal Regulation Information
- FDA Homeopathic Products:
NHFA to FDA, March 2018, Formal Comments in response to the FDA proposed Draft Guidance entitled: Drug Products Labeled as Homeopathic: Guidance for FDA Staff and Industry, Docket ID. FDA-2017-D-6580, Food and Drug Administration – Center for Drug Evaluation and Research (CDER) in cooperation with the Center for Biologics Evaluation and Research (CBER), December 2017.
- Dietary Supplement Product Labeling:
Miller, D, 2007. Freedom of Speech and Truthful Information in Health Care, Alternative and Complementary Therapies.
- CAM and the FDA:
NHFA to FDA, 2007, Formal Comments in response to the FDA proposed Draft Guidance entitled: “Guidance for Industry on Complementary and Alternative Medicine Products and Their Regulation by the Food and Drug Administration” Docket ID. 2006d-0480, Department of Health and Human Services, Food and Drug Administration, December 2006